These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 13808852)

  • 21. Effects of long-term use of antidiabetic sulfonylureas on thyroid weight and arteriosclerosis.
    NIKKILA EA; TEIR H
    Ann Med Exp Biol Fenn; 1960; 38():182-5. PubMed ID: 14427203
    [No Abstract]   [Full Text] [Related]  

  • 22. [The significance of sulfonylureas and biguanide for the treatment of diabetes mellitus].
    MEHNERT H
    Chemotherapia (Basel); 1961; 2():262-82. PubMed ID: 13768997
    [No Abstract]   [Full Text] [Related]  

  • 23. [On the problem of controlling blood picture in the continuous treatment of diabetic patients with sulfonylurea preparations].
    BLOECH J; KOENIGSTEIN RP; LACKNER P; LENHARDT A; MAEHR G
    Wien Klin Wochenschr; 1962 Feb; 74():94-5. PubMed ID: 13870067
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison in rabbits of hypoglycemia and B cell degranulation after various sulfonylureas.
    LAZARUS SS; VOLK BW
    Proc Soc Exp Biol Med; 1959 Oct; 102():67-70. PubMed ID: 14414809
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical use of oral hypoglycemic agents.
    Hagg SA
    Am J Hosp Pharm; 1976 Sep; 33(9):943-7. PubMed ID: 790951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sulfonylureas.
    Kalra S; Gupta Y
    J Pak Med Assoc; 2015 Jan; 65(1):101-4. PubMed ID: 25831689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Inhibitory effects of sulfonylureas (hypoglycemic agents) on the color reaction using oxidase].
    Sakoguchi T; Kitani Y; Kimura M; Hase A; Kobayashi K; Matsuoka A
    Rinsho Byori; 1982 May; 30(5):533-7. PubMed ID: 7131818
    [No Abstract]   [Full Text] [Related]  

  • 28. [Selective destruction of the alpha cells of the islets of the pancreas in rabbits by administration of chloride of cobalt. Its relation to the mechanism of action of sulfonylureas].
    VAISSMAN I; da SILVA I; PEDERSOLI WM
    Med Cir Farm; 1959 Sep; 281():402-14. PubMed ID: 13840726
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical and experimental findings after five years' treatment of diabetes with sulfonylureas.
    MEHNERT H
    Diabetes; 1962; 11(Suppl)():80-4. PubMed ID: 13934500
    [No Abstract]   [Full Text] [Related]  

  • 30. Disulfiramlike actions produced by hypoglycemic sulfonylurea compounds.
    TRUITT EB; DURITZ G; MORGAN AM; PROUTY RW
    Q J Stud Alcohol; 1962 Jun; 23():197-207. PubMed ID: 13922688
    [No Abstract]   [Full Text] [Related]  

  • 31. EXPERIMENTAL DIABETES AND THE MODE OF ACTION OF THE SULFONYLUREAS. WITH SOME SPECULATIONS ON THE PREVENTION OF DIABETES.
    FOA PP
    Bull Sinai Hosp Detroit; 1964; 12():31-46. PubMed ID: 14156394
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of long-term sulfonylurea treatment on the haematopoietic system of diabetic patients.
    JAKOBSON T
    Ann Med Intern Fenn; 1961; 50():83-93. PubMed ID: 13789246
    [No Abstract]   [Full Text] [Related]  

  • 33. Actual problems of the hypoglycaemic sulfonylureas.
    Káldor A
    Ther Hung; 1977; 25(2):47-50. PubMed ID: 898117
    [No Abstract]   [Full Text] [Related]  

  • 34. Pancreatic action of the sulfonylureas.
    COLWELL AR; COLWELL JA
    J Lab Clin Med; 1959 Mar; 53(3):376-95. PubMed ID: 13631322
    [No Abstract]   [Full Text] [Related]  

  • 35. Sulfonylureas: background and development of the field.
    Levine R
    Diabetes Care; 1984; 7 Suppl 1():3-7. PubMed ID: 6376027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Studies on sulfonylurea derivates. I. Synthesis and hypoglycemic action of sulfonylureas].
    NITTA Y; ANDO N; IKEDA Y; KOIZUMI M; SHIOYA A
    Yakugaku Zasshi; 1962 Feb; 82():191-4. PubMed ID: 14480060
    [No Abstract]   [Full Text] [Related]  

  • 37. SERUM CONCENTRATION AND URINARY EXCRETION OF ORAL SULFONYLUREA COMPOUNDS: RELATION TO DIABETIC CONTROL.
    SHELDON J; ANDERSON J; STONER L
    Diabetes; 1965 Jun; 14():362-7. PubMed ID: 14298920
    [No Abstract]   [Full Text] [Related]  

  • 38. [Inhibition of insulinase by sulfonylureas].
    STRASSLE R; PLETSCHER A
    Klin Wochenschr; 1957 Jul; 35(14):719-22. PubMed ID: 13515047
    [No Abstract]   [Full Text] [Related]  

  • 39. [POSSIBLE NON-DIABETIC EFFECTS OF SULFONYLUREA].
    BAUER G
    Medico (Eur); 1963; ():117-21. PubMed ID: 14065436
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
    Loubatiéres A; Mariani MM; Ribes G; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.